4Ok uda J,Oh-I J,Koga M,et al.Evaluation of accelerationplethysmograms in dermatology of Lipo PGE1 preparationagainst her pes zoster and neuralgia following her pesJ].JPermalol,1997,24(R):751.
1Tse HF,Kwong YL,Chan JKF,et al.Angiogenesis in ischemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation[J].Lancet,2003,361 (9 351):47-49.
2Yamamoto K,Kondo T,Suzuki S,et al.Molecular evaluation of endothelial progenitor cells in patients with ischemic limbs:therapeutic effect by stem cell transplantation[J].Arterioscler Thromb Vasc Biol,2004,24 (12):192-196.
3Kawamoto A,Asahara T,Losordo DW.Transplantation of endothelial progenitor cells for therapeutic neovascularzation[J].Cardiovasc Radiat Med,2002,3(3-4):221-225.
4Esato K,Hamano K,Li TS,et al.Neovascularzation induced by autologous bone marrow cell implantation in peripheral arteral disease[J].Cell Transplant,2002,11 (8):747 -752.
5Fletcher K. Drug delivery: strategies and technologies [J].PSTT, 1998,1(2):49-52.
6Takenaga M. Application of lipid microspheres for treatment of cancer[J]. Adv Drug Delivery Rev, 1996,20(213): 209-219.
7Gregoriadis G,Senoir J, Poste G. Targeting of drugs with synthetic systems[M]. London: Plenum press, 1996. 209-219.
8Goldferg EP. Targeted drugs [ M ]. New York: John wiley&sons, 1999.1-55.
9Langer R. Drug delivery and targeting[J]. Nature, 1998,393(6684):66-79.
10Nagaich S,Khopade AJ,Jain NK. Lipo grafts of egg-box complex. A new supramolecular biovector for 5-fluorouracil delivery[J]. Pharm Acta Helv, 1999,73(5):227-229.
